Localization of the binding domain of the inhibitory ligand forskolin in the glucose transporter GLUT-4 by photolabeling, proteolytic cleavage and a site-specific antiserum.
The binding domain of forskolin in the adipocyte/muscle-type glucose transporter (GLUT-4) was localized with the aid of the photoreactive derivative, [125I]IAPS-forskolin (3-[125I]iodo-4-azidophenethylamido-7-O-succinyldeacetyl-forskolin). Plasma membranes from insulin-treated rat adipocytes containing predominantly the GLUT-4 isoform were irradiated with UV light in the presence of [125I]IAPS-forskolin. The covalently labeled glucose transporters were isolated by immunoprecipitation with specific antiserum and partially digested with trypsin and elastase. The fragments were separated by gel electrophoresis, transferred on to nitrocellulose membranes, and identified by direct autoradiography and by immunoassay with antiserum against a peptide sequence corresponding to the C-terminus of GLUT-4. Digestion with a high-purity grade trypsin generated two photolabeled fragments with apparent molecular weights of 21 and 16 kDa. Since the antiserum detected two fragments with identical electrophoretic mobility, both labeled fragments appeared to contain the intact C-terminus of GLUT-4. In contrast, digestion with elastase generated only one photolabeled fragment with intact C-terminus at 21 kDa, and a smaller unlabeled fragment with intact C-terminus at 15 kDa. A less pure trypsin preparation generated two labeled (21 and 17 kDa) and one unlabeled (15 kDa) fragment with intact C-terminus. These data suggest that the site of covalent binding of IAPS-forskolin in the GLUT-4 is located within a region of 1-6 kDa defined by the difference between the unlabeled C-terminal fragment (15 kDa) and the labeled fragments (21, 17 and 16 kDa). Based on a tentative allocation of the fragments to the sequence of the GLUT-4, it is suggested that the covalent binding site of IAPS-forskolin is located between the membrane spanning helices 7-9, possibly in the proximity of helix 9.
Hellwig
B
B
Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der RWTH Aachen, Germany.
Brown
F M
FM
Schürmann
A
A
Shanahan
M F
MF
Joost
H G
HG
D000273:Adipose Tissue / Q000737:chemistry*; D000345:Affinity Labels; D000818:Animals; D001386:Azides; D001665:Binding Sites; D002648:Child; D005576:Colforsin / Q000031:analogs & derivatives / Q000032:analysis*; D004224:Diterpenes; D051275:Glucose Transporter Type 4; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D009004:Monosaccharide Transport Proteins / Q000737:chemistry* / Q000276:immunology; D009124:Muscle Proteins; D010196:Pancreatic Elastase; D010446:Peptide Fragments / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D014357:Trypsin
D000345:Affinity Labels; D001386:Azides; D004224:Diterpenes; D051275:Glucose Transporter Type 4; D007106:Immune Sera; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; D010446:Peptide Fragments; C495692:SLC2A4 protein, human; C495694:Slc2a4 protein, rat; C054433:3-iodo-4-azidophenethylamido-7-O-succinyldeacetylforskolin; D005576:Colforsin; D010196:Pancreatic Elastase; D014357:Trypsin